Ontario study confirms Paxlovid’s effectiveness in treating COVID-19
A study of more than 170-thousand Ontario patients saw a significant reduction in hospitalizations for seniors who took Paxlovid
Read MoreA study of more than 170-thousand Ontario patients saw a significant reduction in hospitalizations for seniors who took Paxlovid
Read MoreAfter weeks of going over the data, Health Canada has approved Paxlovid, Pfizer’s anti-viral pill for use in Canada
Read MoreToronto Public health is hosting a large vaccination event Sunday for Northwest residents who still need to get a shot
Read MorePfizer-BioNTech’s COVID-19 vaccine is the first approved by Health Canada for children under 12 and across the country, kids are rolling up their sleeves.
Read MoreMore than 50 per cent of Ontarians aged 18 and older have received their first doses of the COVID-19 vaccines.
Read MoreYounger people living in hotspots throughout the province are eligible to get their COVID-19 vaccine shots.
Read MoreThe federal government signed a deal with Pfizer securing the COVID-19 vaccine until 2023, and an option for the following year.
Read MoreBoth the regular and junior EpiPens are in short supply, according to Pfizer Canada.
Read MoreA $160-billion merger between American firm Pfizer and Irish firm Allergan would create the world’s largest pharmaceutical company.
Read More